Will we learn anything?
Here we are with yet another EASD which basically means there will lots of news this week. The question is will we learn anything from all this news. Sadly I believe the answer is no. The real problem is our wacky world hasn’t gotten the memo yet. Here’s the problem in a nutshell this week you’ll see lots of data about the toys in the toy chest and drugs in...
Mint it
Now that the FDA has approved the Mint patch pump from Beta Bionics the race is on to battle Insulet. Tandem has filed with the FDA for its Tobi platform as has MiniMed with their Fit platform. So it won’t be long now before we have multiple patch pump platforms besides the Omnipod. This as they say is when the fun begins. Let’s take a look at the current state of...
Join the fight
Two things before we get started. First today is the 25th anniversary of the terrorist attacks on the World Trade Center, the Pentagon and United Flight 93. We honor those who needlessly lost their lives that faithful day. We praise the bravery of the first responders and every regular person who joined to help the people of New York. The Towers have been rebuilt, Osma Bin Laden is dead and...
Misleading Results
When MiniMed separated from Medtronic there were many questions the biggest being could management now separated from the mothership turn things around. Looking at today’s results which came in better than anticipated so far so good. However it should be noted that the results were slightly misleading. Thanks to favorable comps sales performance and new pump placements need to be viewed in that perspective. The good news is MiniMed will...
It’s time to see who’s right
Back on April 16th Abbott CEO Robert Ford stated- “You are going to have about 5 million SGLT2 users that are not using the product who will now benefit from having continuous ketone monitoring. “ Now that the FDA has approved the Libre Duo we’re about to find out who's right Robert or I. The general consensus among most in the diabetes community is the Duo provides a data point which is...
Will Sequel join the IPO parade?
As summer is coming to an end and football season is set to kick off attention turns to fall. Fall isn’t just football season it’s also the time for the street to get back to work. Already we have heard that Oura and Dunkin are preparing for IPO’s which makes one wonder whether Sequel the makers of the twiist will join them. When it comes to IPO’s timing is important...
The Path is the same will the destination by any different?
We now have a host of wearables that collect data. Our smartphones has become the epicenter of our personal healthcare universe. It won’t be long before we have wearables/sensors that measure multiple analytes beyond glucose and ketones. A truly engaged user can measure sleep patterns, stress levels, heart rates, activity, etc. It’s also possible thanks to some way cool whiz bang apps to collect food data. All of this data...